Th17 cell function in cancers: immunosuppressive agents or anti-tumor allies?
Marjan Anvar,
No information about this author
Kimiya Rashidan,
No information about this author
Nima Arsam
No information about this author
et al.
Cancer Cell International,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: Oct. 27, 2024
T
helper
(Th)
17
cells,
a
distinct
subset
of
Th
lymphocytes,
are
known
for
their
prominent
interleukin
(IL)-17
production
and
other
pro-inflammatory
cytokines.
These
cells
exhibit
remarkable
plasticity,
allowing
them
to
different
phenotypes
in
the
cancer
microenvironment.
This
adaptability
enables
Th17
promote
tumor
progression
by
immunosuppressive
activities
angiogenesis,
but
also
mediate
anti-tumor
immune
responses
through
employing
setting
or
even
directly
converting
toward
Th1
phenotype
producing
interferon-gamma
(IFN-γ).
dual
role
makes
it
double-edged
sword
encountering
cancer.
In
this
review,
we
aim
elucidate
complexities
cell
function
summarizing
recent
studies
and,
ultimately,
design
novel
therapeutic
strategies,
especially
targeting
milieu,
which
could
pave
way
more
effective
treatments.
Language: Английский
Emerging Mechanisms and Biomarkers Associated with T-Cells and B-Cells in Autoimmune Disorders
Clinical Reviews in Allergy & Immunology,
Journal Year:
2025,
Volume and Issue:
68(1)
Published: Feb. 11, 2025
Language: Английский
Leveraging Multi-tissue, Single-Cell Atlases as Tools to Elucidate Shared Mechanisms of Immune-Mediated Inflammatory Diseases
Published: May 20, 2024
The
observation
that
certain
therapeutic
strategies
for
targeting
inflammation
benefit
patients
with
distinct
immune-mediated
inflammatory
diseases
(IMIDs)
is
exemplified
by
the
success
of
TNF
blockade
in
conditions
including
rheumatoid
arthritis,
ulcerative
colitis
and
skin
psoriasis,
albeit
only
subsets
individuals
each
condition.
This
suggests
intersecting
"nodes"
networks
at
a
molecular
cellular
level
may
drive
and/or
maintain
IMIDs,
being
“shared”
between
traditionally
diagnoses
without
mapping
neatly
to
single
clinical
phenotype.
In
line
this
proposition,
integrative
tumour
tissue
analyses
oncology
have
highlighted
novel
cell
states
acting
across
diverse
cancers,
important
implications
precision
medicine.
Drawing
upon
advances
field,
narrative
review
will
first
summarise
learnings
from
Human
Cell
Atlas
health
as
platform
interrogating
IMID
tissues.
It
then
cross-disease
studies
date
inform
endeavour,
before
considering
future
directions
field.
Language: Английский
Leveraging Multi-tissue, Single-Cell Atlases as Tools to Elucidate Shared Mechanisms of Immune-Mediated Inflammatory Diseases
Published: June 6, 2024
The
observation
that
certain
therapeutic
strategies
for
targeting
inflammation
benefit
patients
with
distinct
immune-mediated
inflammatory
diseases
(IMIDs)
is
exemplified
by
the
success
of
TNF
blockade
in
conditions
including
rheumatoid
arthritis,
ulcerative
colitis
and
skin
psoriasis,
albeit
only
subsets
individuals
each
condition.
This
suggests
intersecting
"nodes"
networks
at
a
molecular
cellular
level
may
drive
and/or
maintain
IMIDs,
being
“shared”
between
traditionally
diagnoses
without
mapping
neatly
to
single
clinical
phenotype.
In
line
this
proposition,
integrative
tumour
tissue
analyses
oncology
have
highlighted
novel
cell
states
acting
across
diverse
cancers,
important
implications
precision
medicine.
Drawing
upon
advances
field,
narrative
review
will
first
summarise
learnings
from
Human
Cell
Atlas
health
as
platform
interrogating
IMID
tissues.
It
then
cross-disease
studies
date
inform
endeavour,
before
considering
future
directions
field.
Language: Английский
Leveraging Multi-Tissue, Single-Cell Atlases as Tools to Elucidate Shared Mechanisms of Immune-Mediated Inflammatory Diseases
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(6), P. 1297 - 1297
Published: June 12, 2024
The
observation
that
certain
therapeutic
strategies
for
targeting
inflammation
benefit
patients
with
distinct
immune-mediated
inflammatory
diseases
(IMIDs)
is
exemplified
by
the
success
of
TNF
blockade
in
conditions
including
rheumatoid
arthritis,
ulcerative
colitis,
and
skin
psoriasis,
albeit
only
subsets
individuals
each
condition.
This
suggests
intersecting
“nodes”
networks
at
a
molecular
cellular
level
may
drive
and/or
maintain
IMIDs,
being
“shared”
between
traditionally
diagnoses
without
mapping
neatly
to
single
clinical
phenotype.
In
line
this
proposition,
integrative
tumour
tissue
analyses
oncology
have
highlighted
novel
cell
states
acting
across
diverse
cancers,
important
implications
precision
medicine.
Drawing
upon
advances
field,
narrative
review
will
first
summarise
learnings
from
Human
Cell
Atlas
health
as
platform
interrogating
IMID
tissues.
It
then
cross-disease
studies
date
inform
endeavour
before
considering
future
directions
field.
Language: Английский
Longitudinal analysis at pre- and post-flare of T peripheral helper and T follicular helper subsets in patients with systemic lupus erythematosus
Noriyasu Seki,
No information about this author
Hideto Tsujimoto,
No information about this author
Shuhei Tanemura
No information about this author
et al.
Immunology Letters,
Journal Year:
2024,
Volume and Issue:
269, P. 106905 - 106905
Published: Aug. 3, 2024
We
focused
to
analyze
the
time-course
changes
at
pre-
and
post-flare
of
T
peripheral
helper
(Tph)
cells
circulating
follicular
(Tfh)
in
blood
patients
with
systemic
lupus
erythematosus
(SLE)
low
disease
activity
state
(LLDAS)
before
flare.
Language: Английский